Prevalence of depression and anxiety symptoms by liver disease etiology

Abstract

DEP and ANX are prevalent in patients with LD. These associations persist even when considering multiple LD etiologies. Subsequently, DEP and ANX should not be underestimated in patients with LD, particularly since there is a growing body of evidence that both comorbidities can negatively impact patient-centered outcomes. Numerous well-validated, brief measures for assessing DEP and ANX in patients with LD are widely available, and both psychotropic medication management and/or psychological counseling are well-known treatments for these comorbidities. However, more targeted DEP and ANX treatment studies for patients with LD are needed at this time, particularly investigations that focus on the efficacy of affective symptom treatment within samples of patients diagnosed with varying LD etiologies.